EXOZ logo
EXOZ NASDAQ US

eXoZymes Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Nov 2024
$8.74
▲ +$0.30 (+3.55%)
Vol 4K
4
Quality Score
fail
Mkt Cap
$91.4M
ROE
-104.5%
D/E
2.22
Beta
1.21
52W
$9–$24

Price Chart

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -104.5%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 1.79 0.00 1.79 1.79 1.79 2.22
Current Ratio 6.19 6.52 6.19 6.19 6.19 4.53

Key Ratios

ROA (TTM)
-79.5%
EPS (TTM)
$-1.76
52W High
$23.99
52W Low
$8.86
$8.86 52-Week Range $23.99

How does EXOZ compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

EXOZ AAPG ABEO ABOS ABP

EXOZ valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

EXOZ profitability vs Biotechnology peers

ROE
-104.5%
55% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-79.5%
70% below peers (-46.7%)
vs Peers
vs Industry
Weak

EXOZ financial health vs Biotechnology peers

D/E ratio
2.2
0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
4.5
2% above peers (4.4)
vs Peers
vs Industry
In line
Beta
1.2
25% above peers (1.0)
vs Peers
vs Industry
More volatile

EXOZ fundamentals radar

EXOZ Peer median Industry

EXOZ profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

EXOZ vs peers: key metrics

Latest News

No related news yet